ArticleHepatology communications2022

Clinical and demographic predictors of survival for fibrolamellar carcinoma patients-A patient community, registry-based study.

Amichai Berkovitz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.